Teva Pharmaceutical Industries Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

28,60 EUR -0,30 EUR -1,04 %

12.02.2026

BMN

33,92 USD -0,36 USD -1,05 %

12.02.2026

BTT

Teva Pharmaceutical Industries jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

KGV25,54Div. Rendite0,00%

WKN883035

ISINUS8816242098

SymbolTEVA

Teva Pharmaceutical Industries Aktien News

Sortieren:Datum Meistgelesen

28.05.25ZacksTEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate

27.05.25GlobeNewswireTeva Celiac Disease Candidate Granted Fast Track Designation by US FDA

27.05.25GlobeNewswireTeva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June

27.05.25BenzingaWhy Is Teva Stock Trading Higher On Tuesday?

27.05.25ZacksTEVA Stock Up Around 13% in a Month: Buy, Sell or Hold the Stock?

27.05.25GlobeNewswireTeva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

22.05.25GlobeNewswireTeva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

20.05.25GlobeNewswireTeva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt

20.05.25GlobeNewswireFitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy

19.05.25GlobesTeva recycling debt after rating upgrade

19.05.25GlobeNewswireTeva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031

19.05.25GlobeNewswireTeva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes

16.05.25GlobeNewswireMoody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

12.05.25MotleyFoolWhy Teva Pharmaceuticals Stock Blasted 6% Higher Today

12.05.25GlobeNewswireTeva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

12.05.25GlobesTrump post on slashing drug prices sends Teva tumbling

11.05.25GlobesTeva to lay off an estimated 250-300 employees in Israel

08.05.25ZacksTEVA Beats on Q1 Earnings, Expects $700M Cost Savings by 2027, Stock Up

07.05.25MotleyFoolWhy Teva Pharmaceutical Stock Is Soaring Today

07.05.25BenzingaTeva Shares Climb On Profit Beat, $700 Million Cost Plan, Biopharma Pivot Momentum

07.05.25ZacksTeva Pharmaceutical Industries (TEVA) Reports Q1 Earnings: What Key Metrics Have to Say

07.05.25GlobesTeva to lay off 3,000 employees

07.05.25GlobeNewswireTeva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

05.05.25BenzingaWhy Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?

05.05.25ZacksTeva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?

05.05.25ZacksWhat Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q1 Earnings

05.05.25GlobesTeva receives FDA approval for biosimilar

05.05.25GlobeNewswireTeva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

30.04.25BenzingaWhat Does the Market Think About Teva Pharmaceutical Indus?

29.04.25GlobesPrilenia signs deal for former Teva ALS drug worth up to €500m

16.04.25ZacksZacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals

07.04.25GlobeNewswireTeva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

07.04.25GlobeNewswireTeva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

31.03.25GlobeNewswireNew Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-

27.03.25GlobeNewswireTeva Releases Q1 2025 Aide Memoire

27.03.25GlobeNewswireTeva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

14.03.25PR NewswireTeva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma

06.03.25BenzingaForecasting The Future: 6 Analyst Projections For Teva Pharmaceutical Indus

03.03.25GlobeNewswireTeva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

27.02.25GlobeNewswire2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

Teva Pharmaceutical Industries News

Teva Pharmaceutical Industries News: auf dieser Seite finden Sie alle Teva Pharmaceutical Industries News und Nachrichten zur Teva Pharmaceutical Industries Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Teva Pharmaceutical Industries News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Teva Pharmaceutical Industries News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.